Milestone Pharmaceuticals Inc.
MIST
$2.15
$0.073.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 82.59M | 43.42M | 55.96M | 69.70M | 76.42M |
| Total Receivables | 1.45M | 1.34M | 1.49M | 1.72M | 1.99M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.58M | 748.00K | 2.36M | 1.84M | 2.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 60.00K | 668.00K | 674.00K | 674.00K | 61.00K |
| Total Current Assets | 86.67M | 46.17M | 60.48M | 73.93M | 80.99M |
|
|
|||||
| Total Current Assets | 86.67M | 46.17M | 60.48M | 73.93M | 80.99M |
| Net Property, Plant & Equipment | 1.08M | 1.25M | 1.41M | 1.57M | 1.72M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 87.75M | 47.42M | 61.89M | 75.50M | 82.71M |
|
|
|||||
| Total Accounts Payable | 3.18M | 2.93M | 2.38M | 1.93M | 1.63M |
| Total Accrued Expenses | 6.86M | 5.84M | 10.04M | 5.62M | 3.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 483.00K | 515.00K | 542.00K | 571.00K | 582.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.52M | 9.28M | 12.96M | 8.13M | 5.26M |
|
|
|||||
| Total Current Liabilities | 10.52M | 9.28M | 12.96M | 8.13M | 5.26M |
| Long-Term Debt | 56.21M | 55.24M | 54.29M | 53.35M | 52.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 519.00K | 641.00K | 758.00K | 874.00K | 1.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 67.25M | 65.16M | 68.01M | 62.35M | 58.69M |
|
|
|||||
| Common Stock & APIC | 378.05M | 330.45M | 329.11M | 327.62M | 326.12M |
| Retained Earnings | -413.19M | -401.27M | -388.31M | -367.55M | -355.18M |
| Treasury Stock & Other | 55.65M | 53.08M | 53.08M | 53.08M | 53.08M |
| Total Common Equity | 20.50M | -17.75M | -6.12M | 13.15M | 24.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.50M | -17.75M | -6.12M | 13.15M | 24.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.50M | -17.75M | -6.12M | 13.15M | 24.01M |
|
|
|||||